View Enquiry List Akoya Biosciences
Akoya Biosciences’ history represents the rapid advancement driving the field of multiplexed biomarker analysis and immunofluorescence tissue analysis. Today’s Akoya portfolio spans the spectrum from powerful tools for the discovery of important biomarkers to clinical research applications.
Akoya Biosciences was founded in 2015 to commercialize the CODEX System to enable ultra-high multiplexing for biomarker discovery. The fundamental CODEX technology was developed in the lab of Dr. Garry Nolan at Stanford University, who has served as a pioneer in technological and computational methods to enable a better understanding of tissue architecture and its contribution to disease pathology.
The Phenoptics™ technology was originally conceived and developed by Cambridge Research & Instrumentation, co-founded by Peter Miller and Cliff Hoyt, acquired by Caliper in 2010, which was subsequently acquired by PerkinElmer in 2011. The Phenoptics™ technology was promptly adopted as the industry standard for multiplexed tissue analysis for translational and clinical research.
The partnership between PerkinElmer and Telegraph Hill Partners, announced in November of 2018, created the current Akoya Biosciences. This combined portfolio of complementary technologies will continue to fuel groundbreaking advancements in cancer immunology, immunotherapy and a wide range of pathology research.
Watch the Akoya on-demand webinar and find out more about spatial phenotyping:
https://www.akoyabio.com/webinars/
These Opal detection kits allow user to perform multiplex staining using an automated staining platform. Automation provides the flexibility to support the dynamic demands of translational research
These Opal kits offer users a manual method that is similar to standard immunohistochemistry (IHC) making them accessible to many laboratories where standard IHC method development is performed.
These ready-to-use ancillary reagents, from diluents to secondary antibodies and blocking buffers, have been optimized specifically for Opal™ multiplex fluorescent immunohistochemistry protocols
Standalone Opal Fluorophore reagent packs allow you to pick and choose your panel’s biomarker quantity and design.
Opal 7-Color Automation IHC Kit 50 Slide. Opal™ is a practical workflow for the simultaneous detection of up to six tissue biomarkers plus nuclear counterstain within a single image. The method is similar to standard immunohistochemistry (IHC).
![[Obsolete] Vectra 3 Automated Quantitative Pathology Imaging System](https://www.gaiascience.com.my/panel/public/storage/productitems/1762772062_aM05tZ.png)
The Mantra 2™ Quantitative Pathology Workstation incorporates multispectral imaging technology, image acquisition and analysis with the inForm® software, and can be used with a variety of stains including Akoya’s Opal™ reagent kits.
Simplify your biomarker discovery and validation with the new PhenoImager™ Fusion instrument.
